| Open Document File Size: 1,64 MBShare Result on Facebook
Company Bayer / / Event FDA Phase / Product Issues / / MedicalCondition pulmonary arterial hypertension / Pulmonary Hypertension CTEPH / endothelial dysfunction / chronic obstructive pulmonary disease / ventricular disease / chronic thromboembolic pulmonary hypertension / COPD / interstitial lung disease / pulmonary hypertension / / MedicalTreatment surgery / surgical treatment / / Organization Riociguat Cardiovascular and Renal Drugs Advisory Committee / World Health Organization / / Position PhD Vice President Head / / Product synthesis / CTEPH / PATENT-1 / CI-6 / / Technology pre-specified algorithm / /
SocialTag |